Safety and Tolerability of Buprenorphine/Naloxone Film Strips

PHASE2CompletedINTERVENTIONAL
Enrollment

382

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Opioid-Related Disorders
Interventions
DRUG

Buprenorphine/naloxone Film Strip

Buprenorphine/naloxone dosed between 4/1 mg to 32/8 mg once a day for 12 weeks by sublingual route

DRUG

Buprenorphine/naloxone Film Strip

Buprenorphine/naloxone dosed between 4/1 mg to 32/8 mg once a day for 12 weeks by buccal route

Trial Locations (3)

32250

Beeches Family Medicine, Jacksonville Beach

35215

Parkway Medical Center, Birmingham

35565

Winston Technology Research LLC, Haleyville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Indivior Inc.

INDUSTRY

NCT00640835 - Safety and Tolerability of Buprenorphine/Naloxone Film Strips | Biotech Hunter | Biotech Hunter